Keith W. Schmidt
Nessuna posizione attualmente
Profilo
Keith W.
Schmidt served as Vice President at Syntex Laboratories, Inc. and Hoffmann-La Roche, Inc. He was also the Vice President of Sales & Marketing at Chelsea Therapeutics International Ltd.
from 2006 to 2012 and later became the Chief Commercial Officer in 2014.
Schmidt was the President of Tellico Pharma LLC and Vice President at Thomson Healthcare Advanced Therapeutics Communications.
He also served as the Chief Commercial Officer at Ballantyne Therapeutics, Inc. Schmidt earned an undergraduate degree from South Dakota State University and an MBA from the University of San Francisco.
Precedenti posizioni note di Keith W. Schmidt
Società | Posizione | Fine |
---|---|---|
AVALO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/06/2020 |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Corporate Officer/Principal | 23/06/2014 |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Vendite & Marketing | 10/07/2012 |
Thomson Healthcare Advanced Therapeutics Communications | Corporate Officer/Principal | 01/05/2005 |
Ballantyne Therapeutics, Inc.
Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Corporate Officer/Principal | - |
Formazione di Keith W. Schmidt
South Dakota State University | Undergraduate Degree |
University of San Francisco | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Chelsea Therapeutics International Ltd.
Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Syntex Laboratories, Inc. | |
Tellico Pharma LLC | |
Thomson Healthcare Advanced Therapeutics Communications | |
Ballantyne Therapeutics, Inc.
Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Health Technology |
- Borsa valori
- Insiders
- Keith W. Schmidt